1. "2018"
Formats
  1. Journal Article (3011)
  2. Meeting Abstract (1948)
  3. Book Section (206)
  4. Conference Paper (38)
  5. Book Whole (11)
  6. Editorial (4)
  7. Review (4)
  8. Miscellaneous (2)
  9. Correspondence (1)
Groups
  1. Department of Medicine (2296)
  2. Solid Tumor Oncology Division (1378)
  3. GSK Faculty (1136)
  4. Sloan Kettering Institute Postdocs (1044)
  5. Surgery (870)
  6. Center for Hematologic Malignancies (863)

More Groups

People
  1. Sergio Giralt (87)
  2. Matthew Hellmann (78)
  3. Jedd Wolchok (74)
  4. Marc Ladanyi (74)
  5. Robert Motzer (71)
  6. Nancy Lee (64)

More People

Years
  1. 2018 (5225)
Publications
  1. Journal of Clinical Oncology (562)
  2. Blood (249)
  3. Cancer Research (183)
  4. Annals of Oncology (140)
  5. International Journal of Radiation Oncology, Biology, Physics (137)
  6. Modern Pathology (127)

More Publications

Publishers
  1. Elsevier Inc. (691)
  2. American Society of Clinical Oncology (605)
  3. Springer (410)
  4. American Association for Cancer Research (299)
  5. Oxford University Press (291)
  6. American Society of Hematology (273)

More Publishers

Results (5225)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • RET-rearranged lung cancers: Immunophenotype and response to immunotherapy
    Meeting Abstract

    Sabari, J. K.; Offin, M. D.; Wu, S. L.; Ni, A.; Halpenny, D.; Montecalvo, J.; Liu, D.; Pak, T. K.; Arbour, K. C.; Lai, W. C. V.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Malignant wounds associated with cancer: Delay in treatment, impairment in quality of life and associated psychosocial and financial burden
    Meeting Abstract

    Rosenbaum, B. E.; Dusza, S. W.; Goldfarb, S. B.; Barker, C. A.; Markova, A.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Randomized controlled trial of cryotherapy to prevent paclitaxel-induced peripheral neuropathy (RU221511I): An ACCRU trial
    Meeting Abstract

    Ruddy, K. J.; Le-Rademacher, J.; Lacouture, M. E.; Wilkinson, M.; Onitilo, A. A.; Vander Woude, A. C.; Perdekamp, M. T. G.; Dockter, T.; Tan, A. D.; Beutler, A. S.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • EORTC QLQ-C30 (QLQ-C30) symptoms in patients (pts) with HER2-negative metastatic breast cancer (mBC) and a germline BRCA mutation (gBRCAm) receiving olaparib vs chemotherapy treatment of physician's choice (TPC) in OlympiAD
    Meeting Abstract

    Robson, M. E.; Ruddy, K. J.; Im, S. A.; Senkus-Konefka, E.; Xu, B.; Domchek, S. M.; Masuda, N.; Li, W.; Tung, N. M.; Armstrong, A. C.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • EV-201 Study: A single-arm, open-label, multicenter study of enfortumab vedotin for treatment of patients with locally advanced or metastatic urothelial cancer who previously received immune checkpoint inhibitor therapy
    Meeting Abstract

    Rosenberg, J. E.; Heath, E. I.; O'Donnell, P. H.; Hahn, N. M.; Balar, A. V.; Gartner, E. M.; Melhem-Bertrandt, A.; Petrylak, D. P.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • An integrated medical oncology-psychiatry practice model improves overall patient functionality of prostate cancer patients by identifying, quantifying and treating the pre-existing non-cancer co-morbidities
    Meeting Abstract

    Ruppert, L. M.; Dayan, E. S.; Bacharach, A.; Scher, H. I.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Updated results from the enfortumab vedotin phase 1 (EV-101) study in patients with metastatic urothelial cancer (mUC)
    Meeting Abstract

    Rosenberg, J. E.; Sridhar, S. S.; Zhang, J.; Smith, D. C.; Ruether, J. D.; Flaig, T. W.; Baranda, J. C.; Lang, J. M.; Plimack, E. R.; Sangha, R. S.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Outcomes based on age in the phase 3 CELESTIAL trial of cabozantinib (C) versus placebo (P) in patients (pts) with advanced hepatocellular carcinoma (HCC)
    Meeting Abstract

    Rimassa, L.; Cicin, I.; Blanc, J. F.; Klümpen, H. J.; Zagonel, V.; Tran, A.; Kim, S. C. H.; Lin, Z. Z.; Tam, V. C.; Hazra, S.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Primary analysis of phase 2 results for cemiplimab, a human monoclonal anti-PD-1, in patients with metastatic cutaneous squamous cell carcinoma (mCSCC)
    Meeting Abstract

    Rischin, D.; Migden, M. R.; Chang, A.; Chung, C. H.; Dunn, L.; Guminski, A.; Hauschild, A.; Hernandez-Aya, L.; Hughes, B. G. M.; Lewis, K. D.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Clinical and molecular features predicting long-term response (LTR) to anti-PD-(L)1 based therapy in patients with NSCLC
    Meeting Abstract

    Rizvi, H.; Plodkowski, A. J.; Tenet, M.; Halpenny, D.; Long, N.; Sauter, J. L.; Sanchez-Vega, F.; Chatila, W. K.; Schultz, N.; Ladanyi, M.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save